Jonathan McNeill
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Dyne Therapeutics, Inc. (DYN)
Proxy statement
Current -
2022-01-01–2026-06-02
-
2022-01-01–2026-06-02
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Dyne Therapeutics, Inc. (DYN) | Chief Business Officer | $430,468 | $2,230,830 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.